T138067
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T138067, covering 2014-01-06 to 2014-01-06. Get the full timeline:
Most recent: Clinical Trial Update: T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy [Phase 2]